Cargando…

Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis

BACKGROUND: Consumption of oral contraceptive pills (OCP) is a known risk factor for cerebral venous and sinus thrombosis (CVST) among women. We determined whether misuse of OCP could increase the risk of CVST in women. METHODS: A case-control study was conducted from 2003 to 2007 on 64 female patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadatnia, Mohammad, Naghavi, Neda, Fatehi, Farzad, Zare, Mohammad, Tajmirriahi, Marzieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526127/
https://www.ncbi.nlm.nih.gov/pubmed/23267395
_version_ 1782253508749164544
author Saadatnia, Mohammad
Naghavi, Neda
Fatehi, Farzad
Zare, Mohammad
Tajmirriahi, Marzieh
author_facet Saadatnia, Mohammad
Naghavi, Neda
Fatehi, Farzad
Zare, Mohammad
Tajmirriahi, Marzieh
author_sort Saadatnia, Mohammad
collection PubMed
description BACKGROUND: Consumption of oral contraceptive pills (OCP) is a known risk factor for cerebral venous and sinus thrombosis (CVST) among women. We determined whether misuse of OCP could increase the risk of CVST in women. METHODS: A case-control study was conducted from 2003 to 2007 on 64 female patients with CVST admitted to Al- Zahra medical center and 232 healthy age-matched female OCP users as controls. Patients and controls were interviewed and misuse of OCP was categorized to taking OCP for self-treatment of dysfunctional uterine bleeding, for family planning without physician consult, or for delaying menstruation in purpose of religious customs or traveling, and taking OCP in high dose during the preceding year. RESULTS: Among 64 cases and 232 controls, 30 (46.9 %) and 63 (27.2 %), respectively, had a history of OCP misuse (Odds Ratio = 2.36, 95% Confidence Intervals = 1.33 to 4.18, P = 0.002). Also, using cyproterone compound (Diane) was more frequent in the CVST group (P<0.001). Multivariate analysis controlling for age, OCP misuse, type of OCP, and history of coagulopathy showed that OCP misuse (P<0.001) and using Diane as the OCP (P = 0.006) were both independently associated with CVST. DISCUSSION: OCP misuse can be considered as an additional predisposing factor for CVST among women and partly responsible for larger proportion of female patients with CVST. These findings should alarm the healthcare system to create strategies controlling the inappropriate use of OCP among Iranian women.
format Online
Article
Text
id pubmed-3526127
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35261272012-12-24 Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis Saadatnia, Mohammad Naghavi, Neda Fatehi, Farzad Zare, Mohammad Tajmirriahi, Marzieh J Res Med Sci Original Article BACKGROUND: Consumption of oral contraceptive pills (OCP) is a known risk factor for cerebral venous and sinus thrombosis (CVST) among women. We determined whether misuse of OCP could increase the risk of CVST in women. METHODS: A case-control study was conducted from 2003 to 2007 on 64 female patients with CVST admitted to Al- Zahra medical center and 232 healthy age-matched female OCP users as controls. Patients and controls were interviewed and misuse of OCP was categorized to taking OCP for self-treatment of dysfunctional uterine bleeding, for family planning without physician consult, or for delaying menstruation in purpose of religious customs or traveling, and taking OCP in high dose during the preceding year. RESULTS: Among 64 cases and 232 controls, 30 (46.9 %) and 63 (27.2 %), respectively, had a history of OCP misuse (Odds Ratio = 2.36, 95% Confidence Intervals = 1.33 to 4.18, P = 0.002). Also, using cyproterone compound (Diane) was more frequent in the CVST group (P<0.001). Multivariate analysis controlling for age, OCP misuse, type of OCP, and history of coagulopathy showed that OCP misuse (P<0.001) and using Diane as the OCP (P = 0.006) were both independently associated with CVST. DISCUSSION: OCP misuse can be considered as an additional predisposing factor for CVST among women and partly responsible for larger proportion of female patients with CVST. These findings should alarm the healthcare system to create strategies controlling the inappropriate use of OCP among Iranian women. Medknow Publications & Media Pvt Ltd 2012-04 /pmc/articles/PMC3526127/ /pubmed/23267395 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saadatnia, Mohammad
Naghavi, Neda
Fatehi, Farzad
Zare, Mohammad
Tajmirriahi, Marzieh
Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title_full Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title_fullStr Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title_full_unstemmed Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title_short Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
title_sort oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526127/
https://www.ncbi.nlm.nih.gov/pubmed/23267395
work_keys_str_mv AT saadatniamohammad oralcontraceptivemisuseasariskfactorforcerebralvenousandsinusthrombosis
AT naghavineda oralcontraceptivemisuseasariskfactorforcerebralvenousandsinusthrombosis
AT fatehifarzad oralcontraceptivemisuseasariskfactorforcerebralvenousandsinusthrombosis
AT zaremohammad oralcontraceptivemisuseasariskfactorforcerebralvenousandsinusthrombosis
AT tajmirriahimarzieh oralcontraceptivemisuseasariskfactorforcerebralvenousandsinusthrombosis